Company Description
Acura Pharmaceuticals is working to make it harder to abuse otherwise good drugs. The company has developed a technology to add abuse-deterring...
Key Acura Pharmaceuticals Financials
| Company Type | Public - NASDAQ (CM): ACUR Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $6.4 |
| Employees | -- |
More Acura Pharmaceuticals Financials (7 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Acura Pharmaceuticals's competition across multiple industries
Top Acura Pharmaceuticals Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Acura Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Andrew D. (Andy) Reddick | Network | E-mail |
| SVP, CFO, and Secretary | Peter A. Clemens | Network | E-mail |
| VP Marketing and Administration | James F. Emigh | Network | E-mail |
More Acura Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Acura Pharmaceuticals News
- --Acura Pharmaceuticals Receives $5 Mln Milestone Payment [Midnight Trader] (30 Jun 2008 08:07:00 EDT)
- BioWorld Today June 18, 2008 [BioWorld Today] (18 Jun 2008 00:01:00 EDT)
- SECURITIES AND EXCHANGE COMMISSION NEWS DIGEST [SEC News Digest] (16 Jun 2008 00:01:00 EDT)